SSTR5 and prolactin-producing pituitary gland adenoma: SST5 was expressed in 70.6% (95% CI: 43.6%, 77.9%) of prolactinomas (Fig. 1A) and expressed at a high level in a subset of these cases (IRS ≥ 6 in 8 of 34 cases).